Elizabeth Powell is an Australian scientist who, in collaboration with her colleagues, established an internationally recognised liver research group, which is making significant contributions to the study of liver disease. [1]
Elizabeth Powell is an Australian scientist who, in collaboration with her colleagues, established an internationally recognised liver research group, which is making significant contributions to the study of liver disease. [1]
Elizabeth Powell is a graduate of The University of Queensland Medical School. She completed her early postgraduate training at the Royal Brisbane Hospital and completed her PhD at The University of Queensland. In 1992 she won a Menzies Scholarship to study at Oxford University, UK. [2] She returned in 1994 to take up the position of Director of Clinical Training and Hepatologist at the Princess Alexandra Hospital. Subsequent periods of study included further training at Oxford University and Yale University in the US. [1]
The Liver Research Program led by Professor Powell has helped to shape two new paradigms: the importance of metabolic risk factors in the progression of chronic liver diseases, and more recently proposing altered hepatic regeneration and the ductular reaction as a potential driver of hepatic fibrosis. [1]
The Liver Research Program aims to identify the pathogenic mediators/mechanisms driving chronic liver injury and to develop specific strategies to monitor and improve the outcome of treatment for patients with liver disease. The Research Program will use these strategies to develop new methods for prevention, early detection and personalized treatment for patients.
Current laboratory research activities: - defining the role of altered liver regeneration and repair mechanisms and the regulatory effects of infiltrating monocytes and tissue macrophages in the development of cirrhosis.
Current clinical research activities: - investigating the role of non-invasive techniques to diagnose liver injury and evaluate specific therapeutic interventions to determine whether they favourably modify the natural history of liver disease and are cost-effective.
Liver disease is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.
Andrew Charles Laming is an Australian politician who is currently a member of the House of Representatives representing the Division of Bowman, Queensland, for the Liberal National Party of Queensland, having first won the seat at the 2004 federal election for the Liberal Party of Australia.
The Princess Alexandra Hospital (PAH) is a major Australian teaching hospital of the University of Queensland, located in Brisbane, Queensland. It is a tertiary level teaching hospital with all major medical and surgical specialities onsite except for obstetrics, gynaecology and paediatrics. It has a catchment population of 1.6 million people with 780 beds and 5,800 full-time equivalent staff. In 2005, the hospital received Magnet Recognition.
The QIMR Berghofer Medical Research Institute is an Australian medical research institute located in Herston, Brisbane, in the state of Queensland. QIMR was established in 1945 by the Government of Queensland through the enactment of the Queensland Institute of Medical Research Act 1945 (Qld). Previously known as the Queensland Institute of Medical Research (QIMR), the original purpose of the Institute was to further the study of tropical diseases in North Queensland. The current Director is Professor Frank Gannon. The institute is a registered charity.
The National Health and Medical Research Council (NHMRC) is Australia's peak funding body for medical research, with a budget of roughly $900 million a year. The Council was established to develop and maintain health standards and is responsible for implementing the National Health and Medical Research Council Act 1992.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).
Neuroscience Research Australia is an independent medical research institute based in Sydney, Australia. Previously called the Prince of Wales Medical Research Institute, the institute relaunched as Neuroscience Research Australia on 1 June 2010. NeuRA is accredited by the National Health and Medical Research Council.
Prof (Dr) Subhash Gupta is the Chief liver transplant/hepato-pancreato-biliary surgeon and the Chairman of the Max Center of Liver and Biliary Sciences at Max Hospital, Saket.
Katharina Gaus is an Australian immunologist and molecular microscopist. She is currently an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus uses new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.
Glenda Gobe is a molecular biologist specialising in the molecular controls of apoptosis in kidney disease. She is Co-Director of the Centre for Kidney Disease Research (CKDR), School of Medicine, Translational Research Institute and The University of Queensland and Reader in the Discipline of Medicine at the School of Medicine, University of Queensland.
Gail Garvey is an Indigenous Australian Health Services Researcher with a core focus on Psycho-oncology and Indigenous people. Garvey is a Kamilaroi woman whose family originated from Moree in western New South Wales. She is currently Professor at the Menzies School of Health, where she is Senior Principal Research Fellow and Deputy Division Leader for the Wellbeing and Preventable Chronic Diseases Division.
The Translational Research Institute (TRI) is Australia’s first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.
Professor David Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.
Professor Melissa Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Research laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia.
June Halliday AM is a biochemist and researcher of liver disease and iron metabolism. She is a pioneer in the use of serum ferritin and liver iron concentration as diagnostic aids for studying haemochromatosis.
Professor Wendy Elizabeth Hoy AO is a Fellow of the Australian Academy of Science (FAA), the Director of the Centre for Chronic Disease at the University of Queensland, Australia, and was appointed an Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Sciences in 2015. Hoy's research has involved developing new types of kidney imaging and improving health and lives for indigenous populations, in Australia, Sri Lanka and the USA.
Elizabeth Jane Elliott is an Australian scientist. She is a member of the Order of Australia (AM), for services to paediatrics and child health, as well as a fellow of the AAHMS, and the first female to win the James Cook Medal, awarded by the Royal Society of NSW for contributions to human welfare. She is a Distinguished professor of paediatrics at the University of Sydney and the Sydney Children’s Hospital, Westmead, and regarded as a "pioneer in fetal alcohol spectrum disorder, advocacy and patient care".
Lisa Maher is Professor and head of Viral Hepatitis Epidemiology, at the Kirby Institute for Infection and Immunity, at the University of New South Wales and was made Member of the Order of Australia in 2015. She was awarded an Elizabeth Blackburn Fellowship, in Public Health from the NHMRC, in 2014. She is a fellow of the Australian Academy of Health and Medical Sciences.
Louise Maple-Brown is an endocrinologist and clinical researcher at the Royal Darwin Hospital, serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.